Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × BCG Vaccine × Clear all

Phase

Phase 3 11 Phase 2 6 Phase 1/2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Positron Emission Tomography Computed Tomography 2 fluciclovine F-18 1 abemaciclib 1 Valproic Acid 1 Tetrahydrouridine 1 Sirolimus 1 Positron-Emission Tomography 1 Oncolytic Virotherapy 1 Magnetic Resonance Imaging 1 Lapatinib 1 Ferrosoferric Oxide 1 Fatty Acids, Omega-3 1 BCG Vaccine 1 Aminophylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02326168 2017-01-25

PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡